Author:
Cloos J,Goemans B F,Hess C J,van Oostveen J W,Waisfisz Q,Corthals S,de Lange D,Boeckx N,Hählen K,Reinhardt D,Creutzig U,Schuurhuis G J,Zwaan Ch M,Kaspers G J L
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference16 articles.
1. Rosnet O, Buhring HJ, Marchetto S, Rappold I, Lavagna C, Sainty D et al. Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia 1996; 10: 238–248.
2. Gilliland DG, Griffin JD . The roles of FLT3 in hematopoiesis and leukemia. Blood 2002; 100: 1532–1542.
3. Hayakawa F, Towatari M, Kiyoi H, Tanimoto M, Kitamura T, Saito H et al. Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3 dependent cell lines. Oncogene 2000; 19: 624–631.
4. Yamamoto Y, Kiyoi H, Nakano Y, Suzuki R, Kodera Y, Miyawaki S et al. Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 2001; 97: 2434–2439.
5. Kottaridis PD, Gale RE, Linch DC . Prognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemia. Leukemia Lymphoma 2003; 44: 905–913.
Cited by
148 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献